Division of Endocrinology and Metabolism, Hematology, Rheumatology and Respiratory Medicine, Kagawa University, Kagawa, Japan.
Inflamm Res. 2012 Mar;61(3):233-44. doi: 10.1007/s00011-011-0405-7. Epub 2011 Dec 3.
This study is designed to investigate the role of p38 MAPK in modulating human pulmonary artery endothelial cells (HPAECs) survival and tissue repair functions.
HPAECs (passage 8-12) were used for all experiments. Cells were treated with IL-1β (0.5 or 2 ng/ml) or p38 inhibitor (SB203580 or SB220025, 5 μM each). Cells were also transfected with 50 nM siRNAs. Cell length was measured using ImageJ software. Collagen gel contraction and wound close assay were performed to evaluate tissue repair functions.
IL-1β activated p38 MAPK and induced morphologic change of HPAECs. The p38 inhibitors further augmented IL-1β-induced cell morphologic change, prevented cell death, and augmented collagen gel contraction. Suppression of p38α, γ, or δ, but not p38β resulted in cell morphologic alteration, and suppressing any one of p38 isoforms by siRNAs increased cell survival. Suppression of p38α or δ augmented gel contraction. While p38α suppression stimulated cell migration, suppressing the rest of three isoforms inhibit cell migration. Nuclear factor p65-siRNA blocked IL-1β-induced cell morphologic change, but did not affect p38 inhibitor-induced change.
These findings suggest that p38 MAPK may negatively modulate tissue repair functions of endothelial cells via p65 independent pathway.
本研究旨在探讨 p38MAPK 在调节人肺动脉内皮细胞(HPAECs)存活和组织修复功能中的作用。
所有实验均使用 HPAECs(第 8-12 代)。用白细胞介素-1β(0.5 或 2ng/ml)或 p38 抑制剂(SB203580 或 SB220025,各 5μM)处理细胞。细胞还转染了 50nM 的 siRNA。使用 ImageJ 软件测量细胞长度。进行胶原凝胶收缩和伤口闭合测定以评估组织修复功能。
IL-1β激活了 p38MAPK 并诱导了 HPAECs 的形态变化。p38 抑制剂进一步增强了 IL-1β诱导的细胞形态变化,防止了细胞死亡,并增强了胶原凝胶收缩。抑制 p38α、γ 或 δ,但不是 p38β,导致细胞形态改变,通过 siRNA 抑制任何一种 p38 同工型均可增加细胞存活。抑制 p38α 或 δ 增强了凝胶收缩。虽然抑制 p38α 刺激了细胞迁移,但抑制其余三种同工型则抑制了细胞迁移。核因子 p65-siRNA 阻断了 IL-1β诱导的细胞形态变化,但不影响 p38 抑制剂诱导的变化。
这些发现表明,p38MAPK 可能通过 p65 非依赖性途径负调节内皮细胞的组织修复功能。